Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence.
Saved in:
| Title: | Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence. |
|---|---|
| Authors: | Abu Suleiman, Amro1 (AUTHOR), Quagliariello, Vincenzo2 (AUTHOR), Spadafora, Luigi2,3 (AUTHOR) fedrusso1@gmail.com, Russo, Federico3,4 (AUTHOR), Maurea, Nicola1,3 (AUTHOR) n.maurea@istitutotumori.na.it |
| Source: | Pharmaceuticals (14248247). Jun2026, Vol. 19 Issue 6, p833. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14248247 |
|---|---|
| DOI: | 10.3390/ph19060833 |